Biologic Drugs With Mechanism of Action: Integrin Receptor Antagonists
✉ Email this page to a colleague
Biologic Drugs With Mechanism of Action: Integrin Receptor Antagonists
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Biogen Inc. | TYSABRI | natalizumab | Injection | 125104 | 2004-11-23 | ⤷ Subscribe | ⤷ Subscribe |
Biogen Inc. | TYSABRI | natalizumab | Injection | 125104 | 2004-11-23 | ⤷ Subscribe | ⤷ Subscribe |
Biogen Inc. | TYSABRI | natalizumab | Injection | 125104 | 2004-11-23 | ⤷ Subscribe | ⤷ Subscribe |
Biogen Inc. | TYSABRI | natalizumab | Injection | 125104 | 2004-11-23 | ⤷ Subscribe | ⤷ Subscribe |
Biogen Inc. | TYSABRI | natalizumab | Injection | 125104 | 2004-11-23 | ⤷ Subscribe | ⤷ Subscribe |
Biogen Inc. | TYSABRI | natalizumab | Injection | 125104 | 2004-11-23 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |